Literature DB >> 2867876

Age-related changes in the activities of epoxide hydrolases in different tissues of mice.

S Kaur, S S Gill.   

Abstract

Age-related changes in epoxide hydrolase (EH) activity in the liver, kidney, lung, and intestine were studied in male C57BL/6 mice of 1 through 30 months of age. Hepatic cytosolic EH activity increased until 15 months after which there was a decline of 59% during senescence (30 months). Hepatic EH activity in the mitochondrial fraction increased until 4 months and decreased thereafter with a 43% decline by 30 months. The hepatic microsomal EH activity increased until 6 months followed by decline of 32% by 30 months. All of these increases and declines were statistically significant. Renal cytosolic EH showed maximum activity at 6 months after which the activity decreased significantly with age. However, renal EH activity in the mitochondrial fraction, in general, did not change substantially with age. Although changes in renal microsomal EH activity were small, the decrease in activity at 9-18 months was significantly lower than at 1 month and 23-30 months. EH activity in the cytosolic, mitochondrial and microsomal fractions of kidney was 2.5-, 2-, and 10-fold less, respectively, than that found in similar subcellular fractions of liver. Cytosolic EH activity in lung and intestine and lung microsomal EH showed variations with age. The intestinal microsomal EH was not detectable under the experimental conditions used.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2867876

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  2 in total

Review 1.  Soluble epoxide hydrolase inhibitors and heart failure.

Authors:  Hong Qiu; Ning Li; Jun-Yan Liu; Todd R Harris; Bruce D Hammock; Nipavan Chiamvimonvat
Journal:  Cardiovasc Ther       Date:  2011-04       Impact factor: 3.023

2.  Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase.

Authors:  M F Moghaddam; D F Grant; J M Cheek; J F Greene; K C Williamson; B D Hammock
Journal:  Nat Med       Date:  1997-05       Impact factor: 53.440

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.